53

Syschem (India) LtdBOM 531173 Stock Report

Last reporting period 31 Mar, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XBOM - Bombay Stock Exchange

531173.BO Stock Analysis

53

Uncovered

Syschem (India) Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

2/100

Low score

Market cap $B

0.001

Dividend yield

Shares outstanding

39.86 B

Syschem India Ltd. engages in the manufacture of bulk drug, intermediates, and specialty chemicals. The company is headquartered in Chandigarh, Chandigarh and currently employs 82 full-time employees. The firm is engaged in the manufacturing of bulk drugs/intermediates/specialty chemicals and contract manufacturing. The Company’s products include Amoxycillin Trihydrate; Ampicillin Trihydrate; Cloxacillin Sodium; Dicloxacillin Sodium; Flucloxacillin Sodium for export only; Cephalexin; Cefixime; Cefadroxil; Distillation of Speciality Solvents, such as dimethylformamide (DMF), acetonitrile, ethyl acetate and tetrahydrofuran (THF). The firm has its manufacturing facility at Village Bargodam, Tehsil Kalka, District Panchkula, Haryana.

View Section: Eyestock Rating